Jose Manuel Valdivielso Revilla
Degree: PhD
973 702 952
valdivielso(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/B-5673-2009
Publications
-
Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM
Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD
Clinical Journal Of The American Society Of Nephrology 11 287-296. .
-
Jover, R; Bozic, M; Guzman, C; Sanchez-Campos, S; Garcia-Monzon, C; Valdivielso, JM
VITAMIN D RECEPTOR IS UP-REGULATED IN NAFLD HEPATOCYTES AND IS REQUIRED FOR HIGH FAT DIET-INDUCED STEATOSIS IN APOE(-/-) MICE LIVER
JOURNAL OF HEPATOLOGY 64 682-682. .
-
Marco Mayayo MP; Martinez Alonso M; Valdivielso Revilla JM; Fernandez-Giraldez, E
A New Gender-Specific Formula to Estimate 24-Hour Urine Protein from Protein to Creatinine Ratio
Nephron 133 232-238. .
-
Barrios C; Pascual J; Otero S; Soler MJ; Rodríguez E; Collado S; Faura A; Mojal S; Navarro-González JF; Betriu A; Fernandez E; Valdivielso JM; investigators of the NEFRONA study
Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease
Atherosclerosis 242 37-44. .
-
Bozic M; Álvarez Á; de Pablo C; Sanchez-Niño MD; Ortiz A; Dolcet X; Encinas M; Fernandez E; Valdivielso JM
Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development
PLOS ONE 10 -. .
-
Gracia, M; Valdivielso, JM; Betriu, A; Abajo, M; Arroyo, D; Fernandez, ED
SUBCLINICAL ATHEROMATOSIS PROGRESSION AND ASSOCIATED RISK FACTORS IN CHRONIC KIDNEY DISEASE. THE NEFRONA STUDY
Atherosclerosis 241 14-15. .
-
Martin, M; Valls, J; Betriu, A; Fernandez, E; Valdivielso, JM
Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference
Atherosclerosis 241 264-270. .
-
Anguiano L; Riera M; Pascual J; Valdivielso JM; Barrios C; Betriu A; Mojal S; Fernández E; Soler MJ
Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
NEPHROLOGY DIALYSIS TRANSPLANTATION 30 1176-1185. .
-
Fernández-Laso V; Sastre C; Valdivielso JM; Fernández E; Martín-Ventura JL; Egido J; Blanco-Colio LM
Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases
Atherosclerosis 239 358-363. .
-
Bozic M; Valdivielso JM
The potential of targeting NMDA receptors outside the CNS
Expert Opinion On Therapeutic Targets 19 399-413. .
-
Morgado-Pascual, Jose L.; Rayego-Mateos, Sandra; Valdivielso, Jose M.; Ortiz, Alberto; Egido, Jesus; Ruiz-Ortega, Marta
Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells
BioMed Research International -. .
-
Martínez-Miguel P; Valdivielso JM; Medrano-Andrés D; Román-García P; Cano-Peñalver JL; Rodríguez-Puyol M; Rodríguez-Puyol D; López-Ongil S
The active form of vitamin D, calcitriol, induces a complex dual upregulation of endothelin and nitric oxide in cultured endothelial cells
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 307 1085-1096. .
Projects
- Calprotectin as a new companion biomarker and associated drug target for premature vascular aging in chronic kidney disease and type 2 diabetes
- Papel de la señalizacion renal por IGF en los eventos tempranos de la enfermedad renal crónica
- Crosstalk between vascular vitamin D signaling and bone homeostasis in CKD. Implications in mineral metabolism.
- Estancias de personal docente y/o investigador senior en centros extranjeros 2022
- El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
- Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
- SPAIN CKD CAUSE (SPACKDC)
- Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
- INVESTIGO 2022: Grup de recerca translacional vascular i renal
- Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
- Acciones de Dinamización "Europa Investigación 2020"
- Contratos Sara Borrell